![]() |
||
Tatjana Rundek, MD, PhD
Associate Professor of Neurology Director, Clinical Translational Research Division Miller School of Medicine, University of Miami Email: trundek@med.miami.edu Education:
Psychiatry and Neurology Office Location: 1120 NW 14th Street, CRB-1348 Miami, FL 33136 Office Telephone: 305-243-7847 Dr. Tatjana Rundek is an Adjunct Research Faculty at Columbia University in the City of New York and Associate Professor Neurology and a Director of Clinical Translational Research Division in the Department of Neurology of the Miller School of Medicine, the University of Miami. Dr. Rundek graduated from University of Zagreb where she received her medical degree. She received a PhD degree in neuroscience, and trained in neurology at the Grossharden Spital in Munich and at the University Hospital Sisters of Mercy in Zagreb. She received fellowship training in neuroepidemiology at Columbia University. She was an Assistant Professor of Neurology at the Department of Neurology at Columbia University and Director of Non-Invasive Research Vascular Laboratory until she relocated to the University of Miami in 2007. Dr. Rundek is a principal investigator of two NIH funded R01 grants Genetic determinants of carotid atherosclerosis study and Extreme phenotypes of subclinical atherosclerosis and K24 training award Genetic Determinants of Subclinical Atherosclerosis. She is a co-investigator of several NIH-funded epidemiology projects including the Northern Manhattan Study, Family Study of Carotid Atherosclerosis, Oral infection, carotid IMT and risk of stroke, Vascular manifestation of primary hyperparathyroidism, and Aortic arch and risk of stroke, all collaborative projects with the Departments of Medicine and Epidemiology at Columbia University, NY and the University of Miami. She is also a co-investigator of the Albert Einstein Aging study in the Bronx. Dr. Rundek was the Fulbright Scholar and the recipient of the research awards from the Hazel K. Goddess Found to study the relationship between vascular risk factors, subclinical atherosclerosis and stroke in women and the Dr. Gilbert Baum Fund and the American Institute in Ultrasound in Medicine for best clinical application of ultrasound. Dr Rundek research work is directed toward the genetic and environmental determinants of atherosclerosis and use of ultrasound for early detection, intervention and prevention of functional and structural changes of arterial wall in inflammation. Dr. Rundek is also dedicated to promote clinical utility and standards of neurovascular ultrasound. Dr. Rundek is a member of the American Heart Association, American Academy of Neurology, and American Institute of Ultrasound in Medicine. Dr. Rundek serves on the editorial boards of several professional journals including Neurology and Stroke. She is a president elect of the Neurosonology Community Practice of the American Institute of Ultrasound in Medicine. © 2012 The Neurological Institute of New York • 710 W 168th St, New York, NY 10032 Department of Neurology | Columbia University Medical Center | Last updated: December 4, 2012 | Comments |